FDA Moves Ahead With Adverse Event Data-Mining; “White Paper” Out Soon

An FDA-PhRMA working group is finalizing a "white paper" on data mining as a tool in postmarketing safety surveillance

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet